BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DASCS - ECPv4.9.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DASCS
X-ORIGINAL-URL:http://dascs.dk
X-WR-CALDESC:Events for DASCS
BEGIN:VTIMEZONE
TZID:"Europe/Copenhagen"
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID="Europe/Copenhagen":20211124T123000
DTEND;TZID="Europe/Copenhagen":20211124T163000
DTSTAMP:20260828T044604
CREATED:20211022T082334Z
LAST-MODIFIED:20211022T082334Z
UID:1754-1637757000-1637771400@dascs.dk
SUMMARY:Emerging Cell and Gene Therapy
DESCRIPTION:\n\n\n\nInvitation to the R&D Network meeting\nEmerging Cell and Gene Therapies\n\n\n\nMedicon Valley Alliance together with Lund Stem Cell Center\, Lund University have the pleasure to invite you the Medicon Valley Alliance R&D Network meeting on 24th of November\, 2021 in Lund. \n  \nCell and gene therapies are being widely accepted as one of the most transformative innovative trends in biopharmaceuticals. Cell and gene therapies are expected to increasingly shape the medical treatment and diagnosis across a wide range of diseases. Currently there are only a few approved cell and gene therapies on the market which shows that we are still in the early stages of clinical use of these treatments. The global cell and gene therapy market was valued at $4.4 billion in 2020 and is expected to reach $15.5 billion in 2025. \n  \nDespite the clinical\, and commercial\, potential in cell-based therapies the whole process from concept to commercialisation is very demanding and challenging with a constant need for technological improvements\, managing supply chain and manufacturing operations\, regulatory concerns and enabling patient access. \n  \nIn this MVA R&D Network meeting\, hosted by Lund Stem Cell Center\, leading researchers and industry players from the region will share their latest findings as well as discussing opportunities and challenges in developing ground-breaking cell and gene therapies. \n  \nDate: Wednesday\, 24th of November\, 2021\nTime: 12.30 – 16.30 \nVenue: Aulan (Auditorium)\, Skåne University Hospital Lund\, Entrégatan 7\, Lund\, Sweden\nHost: Lund Stem Cell Center \nModerator: Johan Flygare\, Associate Professor\, Lund Stem Cell Center\n\n\n\n
URL:http://dascs.dk/?tribe_events=emerging-cell-and-gene-therapy
LOCATION:Aulan (Auditorium)\, Skåne University Hospital Lund\, Entrégatan 7\, Lund\, Sweden
END:VEVENT
END:VCALENDAR